IBA takes stake in PET Net Germany
Ion Beam Applications (IBA) has taken a minority stake acquisition in PET Net and PET Net Solutions, providers of PET radiopharmaceuticals to nuclear medicine facilities throughout Germany.

The addition of PET Net to IBA’s existing PET provides the company with a local partner in Germany for developing and distributing future proprietary molecules, said the Louvain-la-Neuve, Belgium-based company.

Under the terms of the agreement, IBA has purchased 25.2 percent of PET Net from its owner, Medical Imaging Research Holding. PET Net operates two profitable commercial GMP-certified PET sites located in Erlangen and Regensburg, Germany, has a European marketing authorization for FDG and is a service provider for establishing PET production sites, added IBA.